Hospira Recalls Aminosyn 3.5% Bags Due to Sterility Concerns
Hospira Inc. is recalling 15,258 bags of Aminosyn 3.5% M Sulfite-Free due to a lack of assurance of sterility and potential leakage from the administrative port.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, which corresponds to a Severe rating under the rubric, particularly given the risk of sterility failure in an intravenous product.
Plain-English summary
Hospira Inc. is recalling 15,258 bags of Aminosyn 3.5% M Sulfite-Free, A Crystalline Amino Acid Solution with Maintenance Electrolytes with Phosphorus, 1000 mL bag. The product is prescription-only and was distributed nationwide, including Puerto Rico. The specific lot number is 26-123-JT with an expiration date of 8/14.
The recall was initiated due to a lack of assurance of sterility and the potential for leakage from the administrative port. This defect could compromise the safety of the intravenous solution.
Healthcare providers and patients should stop using the affected product immediately. Consumers should check their inventory for the specific lot number and expiration date listed above and contact their healthcare provider or the manufacturer for further instructions.
The recalled product
- Product
- Aminosyn 3.5% M Sulfite-Free, A Crystalline Amino Acid Solution* with Maintenance Electrolytes with Phosphorus, 1000 mL bag, Rx only. Hospira Inc, Lake Forest, IL, 60045. NDC: 0409-4196-05
- Manufacturer
- Hospira Inc.
- Category
- Drug — Intravenous Solution
- Hazard
- Affected units
- 15,258
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 26-123-JT
- Exp: 8/14
Distribution
Part of a larger recall action
This product is one of 2 recalled by Hospira Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same manufacturer · Hospira Inc.
See all →- CriticalHospira Recalls Dextrose Injection Syringes Due to Human Hair Particulate
FDA (Drugs) · 2017-05-31
- ModerateHospira Recalls Minibore Extension Sets Due to Solvent Occlusion
FDA (Devices) · 2017-01-18
- LowHospira Recalls Lidocaine and Dextrose Injection for Stability Failures
FDA (Drugs) · 2016-12-14
- SevereHospira Recalls Fentanyl Citrate Injection Ampules Due to Broken Tips
FDA (Drugs) · 2016-11-30
- HighHospira Symbiq Infusion Pump Recalled for White Screen Shutdown
FDA (Devices) · 2016-11-16
Same hazard · sterility failure
See all →- SevereAvKare Carboxymethylcellulose Sodium Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereAvKare Carboxymethylcellulose Sodium Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereROHTO DIGI-EYE Eye Drops Recalled Over Sterility Assurance Gap
FDA (Drugs) · 2026-07-29
- HighROHTO DRY-AID Eye Drops Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- SevereOne-Piece Introducer Tray kits recalled for sterility failure
FDA (Devices) · 2026-07-22
Similar recalls
- ModerateHospira Recalls Aminosyn-PF Amino Acid Bags Due to Chemical Contamination
FDA (Drugs) · 2016-04-27
- CriticalHospira Recalls Aminosyn II Amino Acid Injection Due to Particulate Matter
FDA (Drugs) · 2014-01-22
- SevereHospira Recalls Heparin Sodium Bags Due to Sterility Concerns
FDA (Drugs) · 2014-07-16
- SevereHospira Recalls 0.45% Sodium Chloride Injection Due to Sterility Concerns
FDA (Drugs) · 2014-12-03
- SevereHospira Recalls Metronidazole Injection Bags Due to Leaking
FDA (Drugs) · 2017-03-01
- SevereHospira Recalls 0.9% Sodium Chloride Injection Due to Sterility Concerns
FDA (Drugs) · 2013-03-13